West Pharmaceutical Return On Equity vs. Current Valuation

WST Stock  USD 319.52  0.34  0.11%   
Taking into consideration West Pharmaceutical's profitability measurements, West Pharmaceutical Services is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in July. Profitability indicators assess West Pharmaceutical's ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
0.20597015
Current Value
0.22
Quarterly Volatility
0.05345686
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, West Pharmaceutical's Price To Sales Ratio is comparatively stable compared to the past year. EV To Sales is likely to gain to 9.12 in 2024, whereas Days Sales Outstanding is likely to drop 42.73 in 2024. At this time, West Pharmaceutical's Net Income Per Share is comparatively stable compared to the past year.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.260.3828
Way Down
Slightly volatile
Net Profit Margin0.210.2012
Sufficiently Up
Slightly volatile
Operating Profit Margin0.240.2292
Sufficiently Up
Slightly volatile
Pretax Profit Margin0.250.2366
Notably Up
Slightly volatile
Return On Assets0.160.155
Sufficiently Up
Slightly volatile
Return On Equity0.220.206
Notably Up
Slightly volatile
For West Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of West Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well West Pharmaceutical Services utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between West Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of West Pharmaceutical Services over time as well as its relative position and ranking within its peers.
  
Check out Your Current Watchlist.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.16)
Dividend Share
0.78
Earnings Share
7.58
Revenue Per Share
39.549
Quarterly Revenue Growth
(0.03)
The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

West Pharmaceutical Current Valuation vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining West Pharmaceutical's current stock value. Our valuation model uses many indicators to compare West Pharmaceutical value to that of its competitors to determine the firm's financial worth.
West Pharmaceutical Services is rated second in return on equity category among its peers. It is rated fourth in current valuation category among its peers reporting about  108,575,260,499  of Current Valuation per Return On Equity. At this time, West Pharmaceutical's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value West Pharmaceutical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

West Current Valuation vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

West Pharmaceutical

Return On Equity

 = 

Net Income

Total Equity

 = 
0.21
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

West Pharmaceutical

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
22.63 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

West Current Valuation vs Competition

West Pharmaceutical Services is rated fourth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 258.48 Billion. West Pharmaceutical holds roughly 22.63 Billion in current valuation claiming about 9% of equities under Health Care industry.

West Pharmaceutical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in West Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, West Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of West Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of West Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-143.8 M-151 M
Operating Income676 M709.8 M
Income Before Tax698 M732.9 M
Total Other Income Expense Net-28.4 M-27 M
Net Income593.4 M623.1 M
Income Tax Expense122.3 M128.4 M
Net Income Applicable To Common Shares673.8 M707.5 M
Net Income From Continuing Ops593.4 M623.1 M
Non Operating Income Net Other-29.3 M-27.9 M
Interest Income28 M29.4 M
Net Interest Income19 M19.9 M
Change To Netincome34.2 M26.6 M
Net Income Per Share 7.99  8.39 
Income Quality 1.31  1.24 
Net Income Per E B T 0.85  0.58 

West Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on West Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of West Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the West Pharmaceutical's important profitability drivers and their relationship over time.

Use West Pharmaceutical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if West Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in West Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

West Pharmaceutical Pair Trading

West Pharmaceutical Services Pair Trading Analysis

The ability to find closely correlated positions to West Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace West Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back West Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling West Pharmaceutical Services to buy it.
The correlation of West Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as West Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if West Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for West Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your West Pharmaceutical position

In addition to having West Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Restaurants Thematic Idea Now

Restaurants
Restaurants Theme
Entities that are involved in restaurant business, as well as coffee shop chains and other eateries. The Restaurants theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Restaurants Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.